Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

rna Press Releases

  + XML/RSS  



By Golden Helix, Inc.
Today Golden Helix, Inc. announced their first ever t-shirt design contest.

By GATC Biotech
GATC Biotech provides information for research on cell function and on how changes in transcriptional activity may reflect or contribute to diseases.

By Bio-Synthesis, Inc.
The next generation of nucleic acids, provided by Bio-Synthesis, is an ideal solution for the detection of small or highly similar DNA or RNA targets.

By Donald Danforth Plant Science Center
ST. LOUIS, MO, August 12, 2013 – The Donald Danforth Plant Science Center’s "Conversations" series, sponsored by Boeing, will continue on Thursday, August 29, 2013 with a reception at 5:15 p.m. and the program at 6:00 p.m.

By Mary Ann Liebert, Inc., publishers
New classes of drugs that can silence specific genes, such as small interfering RNAs (siRNAs), offer great therapeutic potential. But the specific delivery of siRNAs to target cells to exert their effects remains a significant challenge.

By Mary Ann Liebert, Inc., publishers
By targeting the specific mutation that causes the hereditary neuromuscular disease myotonic dystrophy, it is possible to neutralize the mutant RNA toxicity and minimize or even eliminate the disabling symptoms of the disease.

By Mary Ann Liebert, Inc., publishers
As scientists continue to unravel the complexity of the human genome and to uncover vital elements that play a role in both normal physiology and disease, one particular class of elements called noncoding RNAs is gaining a lot of attention.

By Particular GmbH
While the gold price keeps setting new records, nanoparticles from pure gold are also gaining importance in biotechnology. Particular GmbH from Germany now uses a laser method to produce them with high purity and conjugate them with high efficiency.

All Press Releases

By Golden Helix, Inc.
Today, Golden Helix, Inc. announced a collaboration with Dr. Jeffrey Moore, newly named Howard Hughes Medical Institute Professor of the University of Illinois at Urbana-Champaign.

By Golden Helix, Inc.
Today Golden Helix, Inc. announced their first ever t-shirt design contest.

By GATC Biotech
GATC Biotech provides information for research on cell function and on how changes in transcriptional activity may reflect or contribute to diseases.

By Bio-Synthesis, Inc.
The next generation of nucleic acids, provided by Bio-Synthesis, is an ideal solution for the detection of small or highly similar DNA or RNA targets.

By Donald Danforth Plant Science Center
ST. LOUIS, MO, August 12, 2013 – The Donald Danforth Plant Science Center’s "Conversations" series, sponsored by Boeing, will continue on Thursday, August 29, 2013 with a reception at 5:15 p.m. and the program at 6:00 p.m.

By Mary Ann Liebert, Inc., publishers
New classes of drugs that can silence specific genes, such as small interfering RNAs (siRNAs), offer great therapeutic potential. But the specific delivery of siRNAs to target cells to exert their effects remains a significant challenge.

By Mary Ann Liebert, Inc., publishers
By targeting the specific mutation that causes the hereditary neuromuscular disease myotonic dystrophy, it is possible to neutralize the mutant RNA toxicity and minimize or even eliminate the disabling symptoms of the disease.

By Mary Ann Liebert, Inc., publishers
As scientists continue to unravel the complexity of the human genome and to uncover vital elements that play a role in both normal physiology and disease, one particular class of elements called noncoding RNAs is gaining a lot of attention.

By Mary Ann Liebert, Inc., publishers
Small interfering RNAs (siRNAs) are a potent new drug class that can silence a disease-causing gene, but delivering them to a target cell can be challenging.

By Mary Ann Liebert, Inc., publishers
The use of RNA in nanotechnology applications is highly promising for many applications, including the development of new therapeutic compounds.

By AnaSpec EGT Group
The detection of nucleic acids is important for many life science research tasks, such as sequencing, cDNA synthesis and cloning, RNA transcription and transfection.

By biosyn.com
Bio-Synthesis is able to synthesize ultra long oligonucleotides (RNA and DNA).

By Mary Ann Liebert, Inc., publishers
Small RNA-based nucleic acid drugs represent a promising new class of therapeutic agents for silencing abnormal or overactive disease-causing genes, and researchers have discovered new mechanisms by which RNA drugs can control gene activity.

By Shridhar University
Even though the proponents of a natural origin of life expressed much optimism for providing their theories, presently there is a detailed compilation of information seriously questioning this doctrine.

By Particular GmbH
While the gold price keeps setting new records, nanoparticles from pure gold are also gaining importance in biotechnology. Particular GmbH from Germany now uses a laser method to produce them with high purity and conjugate them with high efficiency.

By Freedom Press
New Book “Extraordinary Healing” recounts life and research of French molecular biologist Dr. Mirko Beljanski

By Insight Pharma Reports
RNAi Therapeutics: Second-Generation Candidates Build Momentum

By Bharatbook
Bharatbook added a new report on "Global miRNA Market Outlook" which provides a comprehensive overview of the miRNA market and its prospects. By RNCOS.

By Melanie Bernds
Dr. William H. Danforth, chairman of the Board of Trustees of the Donald Danforth Plant Science Center, today announced that Dr. James C. Carrington, will become the next President of the Danforth Plant Science Center.

By Insight Pharma Reports
Cambridge Healthtech Institute (CHI) releases its latest Insight Pharma Report, Next-Generation Sequencing Technologies: Applications and Markets, available at InsightPharmaReports.com

By Bill Schappert
Antigene therapy is a promising new treatment strategy that uses a DNA-based drug to pinpoint light energy to a target gene shutting down its activity. A review article published online ahead of print in Oligonucleotides.

By Gerry Skews
SERVA Electrophoresis introduce the Blue Power range of Programmable Laboratory Power Supplies.

By Gerry Skews
SERVA DNA Stain G is a safer alternative to traditional ethidium bromide stain for detecting nucleic acid in agarose gels.

By LevelStock.com
Investors seeking technical and fundamental stock alerts on penny stocks can subscribe to our newsletters today at LevelStock.com

By Tacere Therapeutics, Inc.
Pfizer exercises option to further develop and commercialize Tacere’s Hepatitis C Virus (HCV) compounds.

By Bharatbook
Bharatbook added a new report on "Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma" which gives in-depth analysis on RNA Therapeutics Market.

By Bio-Synthesis, Inc.
Bio-Synthesis, Inc. provides custom products for researchers and pharmaceutical companies

By Angela Ragan
The new uses and benefits of anti-drug antibodies, examined by Bio-Synthesis, Inc.

By Bio-Synthesis, Inc.
Bio-Synthesis has teamed up with BioConference Live for a revolutionary event. BioConference Live is a free, online-only conference for the life sciences and laboratory science community.

By Fred Schlegel
GenUs BioSystems announces a combined miRNA and whole genome gene expression service. Standard combined service for yields as low as 400 nanograms. Special application services are also available for much smaller yields.

By Fred Schlegel
GenUs BioSystems announces a 70% reduction in the minimum RNA yield requirement for standard gene expression services to 300 nanograms. Special services are available for yields down to 100 picograms RNA.

By Mary Ann Liebert, Inc., publishers
A novel class of drugs composed of single strands of DNA or RNA, called aptamers, can bind protein targets with a high strength and specificity and are currently in clinical development as treatments for a broad range of common diseases

By Mary Ann Liebert, Inc., publishers
Small synthetic fragments of genetic material called small interfering RNA (siRNA) can block production of abnormal proteins; however, these exciting new drug candidates can also induce a strong immune response, causing toxic side effects

By Trana Discovery, Inc.
Drug discovery technology company develops tools to find new treatments for serious infectious diseases…

By Colfax International
RNA Networks’ Memory Virtualization Platform Improves HPC Performance and Analysis

By Mary Ann Liebert, Inc., publishers
Systems biology scientists from diverse areas of research are developing a range of methods to model pathways, interpret data, and derive therapeutic targets from biological networks, reports Genetic Engineering and Biotechnology News (GEN).

By Bharatbook
Bharatbook.com is glad to promote new report which focuses on RNA interference markets

By Mary Ann Liebert, Inc., publishers
RNAi represents an innovative new strategy for using small RNA molecules to silence specific genes associated with disease processes, and a series of review articles describing applications of RNAi and microRNAs will begin in Human Gene Therapy.



Page:
  • 1

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share